At 24 weeks, 41.7% of the relapsing participants and 75% of the newly diagnosed patients attained a complete response.

The United States contributed more than half of global public and philanthropic cancer research funding between 2016 and 2023.

Since the 2023 Supreme Court ruling restricting race-based affirmative action, there has been a decline in medical school enrollment among individuals who are already underrepresented in medicine.

Pictured: CT abdomen with contrast showed a new large left retroperitoneal hematoma measuring 17 x 9.3 x 8.2 cm. A 75-year-old woman was admitted to the ...

Rare pathogenic variants in cancer predisposition genes increase the risk of developing single and multiple primary cancers, researchers found.

Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately.

Early prediction and prevention of venous thromboembolism is crucial in high-risk populations, such as hospitalized patients with bladder cancer.

(HealthDay News) — The percentage of U.S. adults using nicotine pouches remains low, according to a research letter published online Sept. 8 in JAMA Network Open.

Lowest representation seen for studies on arrhythmia, coronary heart disease, acute coronary syndrome, and heart failure.

Artificial neural networks based on these biomarkers demonstrated strong predictive ability for AAV risk, validated across multiple data sets and patient renal biopsy samples.

The FDA has approved Enbumyst, a nasal spray formulation of bumetanide, for the treatment of edema associated CHF, and hepatic and renal disease.

Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general population, suggesting it’s a novel risk factor that could enhance prognostic ...